Go on, you can tell me: EU and Canada renew pharma confidentiality arrangements
This article was originally published in SRA
Executive Summary
The European and Canadian drug regulatory agencies have renewed their confidentiality arrangements until 2018, with a provision for tacit renewal of the arrangement for subsequent five-year periods1.